BIOTECHNOLOGY VALUE FUND L P 13D and 13G filings for Immunic, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-02-20 6:59 pm Purchase | 2026-02-12 | 13D | IMMUNIC INC IMUX | BIOTECHNOLOGY VALUE FUND L P | 1,363,060 9.990% | 384,542 (+39.30%) | Filing |
| 2025-08-14 4:02 pm Purchase | 2025-06-30 | 13G | IMMUNIC INC IMUX | BIOTECHNOLOGY VALUE FUND L P | 978,518 9.990% | 88,221 (+9.91%) | Filing |
| 2024-01-18 4:18 pm Purchase | 2024-01-08 | 13G | IMMUNIC INC IMUX | BIOTECHNOLOGY VALUE FUND L P | 890,297 9.900% | 890,297 (New Position) | Filing |